Ana Laus to Epidermal Growth Factor
This is a "connection" page, showing publications Ana Laus has written about Epidermal Growth Factor.
Connection Strength
0.776
-
Laus AC, de Paula FE, de Lima MA, Carlos CD, Gomes INF, de Marchi P, Valente JKN, Pioltini ABM, Miziara JE, da Silva CM, Viana LS, Scapulatempo-Neto C, Reis RM. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Mol Biol Rep. 2019 Apr; 46(2):2417-2425.
Score: 0.607
-
Leal LF, Laus AC, Cavagna R, de Paula FE, de Oliveira MA, Ribeiro DM, Hassan FM, Miziara JE, da Silva ECA, da Silva VD, De Marchi P, Reis RM. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients. Thorac Cancer. 2020 10; 11(10):2987-2992.
Score: 0.169